Aronex Pharma (ARNX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aronex Pharma (ARNX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tara Cobble who wrote (16)	4/11/1997 1:32:00 AM
From: Lance P. Dykhoff	of 320

Tara Read today that Merck was downgraded by three analyst because of a competitor coming out with a drug that could cut in on Merck's cholesteral-lowering drug. Could be the reason the sector is being hit. Merck was down 3.75, Bristol-Meyers down 2.75, Schering-Plough down 1.375 and Pfizer off 1.875. The whole sector was hit. I'm down over 60% on what I got, I'll just hang on intil I can get out without being too bloody. Hopefully this will settle down, phase two will go well and we can get back to where we bought. I'm following Ampex closely right now, made a good chunck of money last year on this company. Expecting a big announcement soon and the price is right if you can get in under 8 or so, current price is 6.625 up .625 today, up 1.00 in the past week. Have your broker check them out, I think good things are about to happen. Checkout Ampex thread on this site. Lance

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next